« J&J versus Merck Stare Down over Remicade | Main | Sigma-Aldrich Presents to 2010 Healthcare Conference »

09/09/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0133f40aa103970b

Listed below are links to weblogs that reference Genzyme shareholders - Wanna be Worth $75+ or $59(-) per share?:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

Derek Low In the Pipeline says this morning (Sept 10th) that Sanofi has never waivered from its offer of $69 per share. Reports of an increased offer are wrong.
http://pipeline.corante.com/archives/2010/09/10/sanofiaventis_its_69share_and_thats_where_it_stays.php

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada